Evidence map›Paper›PMID 39585047›Full record

ArticleNon-coding RNA2024

Comparison of Three Computational Tools for the Prediction of RNA Tertiary Structures.

Frank Yiyang Mao, Mei-Juan Tu, Gavin McAllister Traber, Ai-Ming Yu

Abstract read
In one paragraph

Article in Non-coding RNA, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. AlphaFold3: A Transformer in Life Sciences.Current medicinal chemistry · 2026
    Review
  4. Efficiency and safety of five different agents forFrontiers in molecular biosciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Frank Yiyang MaoDepartment of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, 2700 Stockton Blvd, Sacramento, CA 95817, USA.
Mei-Juan TuDepartment of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, 2700 Stockton Blvd, Sacramento, CA 95817, USA.
Gavin McAllister TraberDepartment of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, 2700 Stockton Blvd, Sacramento, CA 95817, USA.ORCID 0000-0003-3494-9196
Ai-Ming YuDepartment of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, 2700 Stockton Blvd, Sacramento, CA 95817, USA.ORCID 0000-0003-1441-4012

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Barbara L. Shacklett · 2002 to 2026
$84.9M
Novel bioengineered microRNA therapeutics for lung cancerR01CA225958 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Aiming Yu · 2019 to 2026
$3.7M
Novel biologic RNA molecules to modulate HCC metabolismR01CA291771 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Aiming Yu · 2024 to 2026
$2.4M
Predoctoral Training in Pharmacological SciencesT32GM099608 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HELL, JOHANNES W · 2012 to 2021
$2.2M
Training Program in PharmacologyT32GM144303 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Donald M Bers, JOHANNES W HELL · 2022 to 2026
$2.1M
Supplement: Recombinant microRNAs in xenobiotic metabolism and dispositionR35GM140835 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI YU, AIMING · 2021 to 2025
$2.0M
Recombinant microRNAs in xenobiotic and nutrient dispositionR01CA253230 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Meijuan Tu · 2021 to 2026
$1.7M
NCI NIH HHS P30 CA093373NCI NIH HHS R01 CA225958NCI NIH HHS R01 CA253230NCI NIH HHS R01 CA291771NCI NIH HHS R01CA291771, R01CA225958 and R01CA253230NIGMS NIH HHS R35 GM140835NIGMS NIH HHS R35GM140835NIGMS NIH HHS T32 GM099608NIGMS NIH HHS T32 GM144303
6 · The paper itself

Abstract

Understanding the structures of noncoding RNAs (ncRNAs) is important for the development of RNA-based therapeutics. There are inherent challenges in employing current experimental techniques to determine the tertiary (3D) structures of RNAs with high complexity and flexibility in folding, which makes computational methods indispensable. In this study, we compared the utilities of three advanced computational tools, namely RNAComposer, Rosetta FARFAR2, and the latest AlphaFold 3, to predict the 3D structures of various forms of RNAs, including the small interfering RNA drug, nedosiran, and the novel bioengineered RNA (BioRNA) molecule showing therapeutic potential. Our results showed that, while RNAComposer offered a malachite green aptamer 3D structure closer to its crystal structure, the performances of RNAComposer and Rosetta FARFAR2 largely depend upon the secondary structures inputted, and Rosetta FARFAR2 predictions might not even recapitulate the typical, inverted "L" shape tRNA 3D structure. Overall, AlphaFold 3, integrating molecular dynamics principles into its deep learning framework, directly predicted RNA 3D structures from RNA primary sequence inputs, even accepting several common post-transcriptional modifications, which closely aligned with the experimentally determined structures. However, there were significant discrepancies among three computational tools in predicting the distal loop of human pre-microRNA and larger BioRNA (tRNA fused pre-miRNA) molecules whose 3D structures have not been characterized experimentally. While computational predictions show considerable promise, their notable strengths and limitations emphasize the needs for experimental validation of predictions besides characterization of more RNA 3D structures.

Indexed as

3D structurecomputational modelingmicroRNArecombinant RNARNA interferenceRNA structuretherapeutic RNAtRNA

Identifiers

PMID39585047
PMCPMC11587127

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.